- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.06. | Ardent Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.06. | KeyBanc hält an Ardent Health-Bewertung aufgrund positiver politischer Aussichten fest | 1 | Investing.com Deutsch | ||
| 20.06. | KeyBanc maintains Ardent Health rating on positive policy outlook | 3 | Investing.com | ||
| ARDENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 08.06. | Virtual Nursing Saves Hospitals Money on Turnover Costs, Ardent Health CMO Says | 1 | MedCity News | ||
| 23.05. | Ardent Health Partners benennt sich in Ardent Health, Inc. um | - | Investing.com Deutsch | ||
| 23.05. | Ardent Health Partners rebrands as Ardent Health, Inc. | 1 | Investing.com | ||
| 23.05. | Ardent Health Partners, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 23.05. | Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc. | 162 | Business Wire | BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S.... ► Artikel lesen | |
| 19.05. | Ardent Health appoints new chief development officer | 1 | Investing.com | ||
| 12.05. | Loop Capital cuts Ardent Health price target to $19, maintains Buy | 1 | Investing.com | ||
| 07.05. | Ardent Health Partners, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Ardent Health Q1 2025 slides: Revenue up 4%, company reaffirms full-year guidance | 2 | Investing.com | ||
| 06.05. | Ardent Health Partners, Inc. Reveals Climb In Q1 Income | 2 | RTTNews | ||
| 06.05. | Ardent Health Partners GAAP EPS of $0.29 beats by $0.09, revenue of $1.5B in-line | 1 | Seeking Alpha | ||
| 06.05. | Ardent Health Partners, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.04. | Ardent Health Partners sees credit rating upgrade at S&P due to improved credit metrics | 2 | Investing.com | ||
| 28.04. | Ardent Health Partners erhält Bonitätsverbesserung bei S&P aufgrund verbesserter Finanzkennzahlen | - | Investing.com Deutsch | ||
| 09.04. | Guggenheim sets $16 target for Ardent Health stock, rates Buy | 1 | Investing.com | ||
| 31.03. | Ardent Health appoints Dave Caspers as COO | 2 | Seeking Alpha | ||
| 31.03. | Ardent Health Partners, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 58,18 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CAPSOVISION | 3,500 | 0,00 % | CapsoVision Prices IPO Of 5.50 Mln Shares At $5.00/shr | WASHINGTON (dpa-AFX) - CapsoVision Inc. (CV), a commercial-stage medical technology company that develops
advanced imaging and artificial intelligence technologies that are deployed in its... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,990 | -0,68 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 22,010 | 0,00 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
| ALIGNMENT HEALTHCARE | 13,610 | -4,22 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| FRESENIUS | 42,500 | +0,52 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
| PHETON | 18,380 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
| NUTEX HEALTH | 122,29 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 55,45 | -2,03 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,500 | +0,17 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen auf "Buy" mit einem Kursziel von 60 Euro belassen. Julien Dormois fasste in einer am Donnerstag... ► Artikel lesen | |
| GENEDX | 89,79 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
| ONCOLOGY INSTITUTE | 2,440 | 0,00 % | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | ||
| 908 DEVICES | 6,605 | 0,00 % | 908 Devices Inc.: Romanian Customs Authority Adopts 908 Devices' MX908 for Border Security Operations | The handheld mass spectrometers are now in active use for trace detection and identification of drugs and explosives for customs and border patrol applications 908 Devices Inc. (Nasdaq: MASS)... ► Artikel lesen | |
| GOODRX | 5,055 | +1,92 % | GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies |
ARDENT HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 13,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ARDENT HEALTH INC finden Sie auf Wallstreet Online.